Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose

Nuclear Medicine Communications

Volumn 31, Issue 5, 2010, Pages 389-397

  Balogova, Sona ^a,c   Huchet, Virginie ^a   Kerrou, Khaldoun ^a   Nataf, Valerie ^b   Gutman, Fabrice ^a   Antoine, Martine ^b   Ruppert, Anne Marie ^b   Prignon, Aurélie ^a   Lavolée, Armelle ^b   Montravers, Francoise ^a   Mayaud, Charles ^b   Cadranel, Jacques ^b   Talbot, Jean Noël ^a  

^a L'Hôpital Tenon AP HP ^*  (France)

^b HÔPITAL TENON   (France)

^c UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

18F fluorocholine; 18F fluorodeoxyglucose; Bronchioloalveolar cancer; PET computed tomography; Prospective comparison

Indexed keywords

FLUOROCHOLINE F 18; FLUORODEOXYGLUCOSE F 18; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADRENAL METASTASIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; LUNG LESION; LUNG NODULE; MALE; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; CHOLINE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951027430     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283369654     Document Type: Article

References (21)

1. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001; 42 (5 Suppl):1S-93S. (Pubitemid 32423895)
2. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary modules and mass lesions. A meta-analysis. JAMA 2001; 285:914-924.
3. Bryant AS, Cerfolio RJ. The maximum standardized uptake values on integrated FDG PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg 2006; 82:1016-1020. (Pubitemid 44246691)
4. O JH, Yoo IeR, Kim SH, Sohn HS, Chung SK. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies. J Nucl Med 2007; 48:15-21.
5. Higashi K, Ueda Y, Seki H, Yuasa K, Oguchi M, Noguchi T, et al. Fluorine- 18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 1998; 39:1016-1020. (Pubitemid 28270118)
6. Kim BT, Kim Y, Lee KS, Yoon SB, Cheon EM, Kwon OJ, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR 1998; 170:935-939. (Pubitemid 28172876)
7. Marom EM, Sarvis S, Herndon JE, Patz EF Jr. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. Radiology 2002; 223:453-459. (Pubitemid 34454325)
8. Cheran SK, Nielsen ND, Patz EF Jr. False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications. AJR Am J Roentgenol 2004; 182: 1129-1132.
9. Cook GJ, Wegner EA, Fogelman I. Pitfalls and artifacts in 18F-FDG and PET/CT oncologic imaging. Semin Nucl Med 2004; 34:122-133. (Pubitemid 38375467)
10. Hara T, Inagaki K, Kosaka N, Morita T. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. J Nucl Med 2000; 41:1507-1513.
11. Pieterman RM, Que TH, Elsinga PH, Pruim J, van Putten JW,Willemsen AT, et al. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer. J Nucl Med 2002; 43:167-172. (Pubitemid 34151038)
12. Khan N, Oriuchi N, Zhang H, Higuchi T, Tian M, Inoue T, et al. A comparative study of 11C-choline PET and 18F-fluorodeoxyglucose PET in the evaluation of lung cancer. Nucl Med Commun 2003; 24:359-366.
13. Guo J, Higashi K, Yokota H, Nagao Y, Ueda Y, Kodama Y, et al. In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma. J Nucl Med 2004; 45:1334-1339. (Pubitemid 47618532)
14. Higashi K, Ueda Y, Matsunari I, Kodama Y, Ikeda R, Miura K, et al. 11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET. Eur J Nucl Med Mol Imaging 2004; 31:13-21.
15. Shibata H, Nomori H, Uno K, Iyama K, Tomiyoshi K, Nakashima R, et al. (11)C-acetate for positron emission tomography imaging of clinical stage IA lung adenocarcinoma: comparison with (18)F-fluorodeoxyglucose for imaging and evaluation of tumor aggressiveness. Ann Nucl Med 2009; 23:609-616.
16. Tsunezuka Y, Shimizu Y, Tanaka N, Takayanagi T, Kawano M. Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size. World J Surg 2007; 31:314-317. (Pubitemid 46183516)
17. Heyneman LE, Ptaz EF. PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer 2002; 38:261-266. (Pubitemid 35341800)
18. Yap C, Schiepers C, Fishbein M, Phelps ME, Czernin J. FDG PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? Eur J Nucl Med 2002; 29:1166-1173. (Pubitemid 34985361)
19. Goudarzi B, Jacene HA, Wahl RL. Diagnosis and differentiation of bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar components with metabolic and anatomic characteristics using PET/CT. J Nucl Med 2008; 49:1585-1592.
20. Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN. Cancer imaging with fluorine-18-labeled choline derivatives. Semin Nucl Med 2007; 37:420-428. (Pubitemid 47498259)
21. Chun EJ, Lee HJ, Kang WJ, Kim KG, Goo JM, Park CM, et al. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT. Lung Cancer 2009; 65:180-186.